#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Krabbe's disease Hydrocephalus Hyperinsulinism Activated PI3 kinase delta syndrome Pulmonary hypertension Stevens-Johnson syndrome Hepatitis D Bronchiectasis Philadelphia chromosome positive Alternating hemiplegia of childhood Glycogen storage disease type II Mantle cell lymphoma refractory Fibrodysplasia ossificans progressiva Medullary thyroid cancer Transitional cell cancer of the renal pelvis and ureter More trials…

    Learn about Rare Diseases

    Shprintzen-Goldberg syndrome – Basic Information Rhabdoid tumour – Trials in Disease Fragile X syndrome – Trials in Disease Myelodysplastic syndrome with excess blasts – Diagnostics Synovial sarcoma recurrent – Trials in Disease Alport’s syndrome – Trials in Disease Medulloblastoma – Treatment Castleman’s disease – Life with Disease Lymphangioma – Diagnostics Malignant fibrous histiocytoma – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Salbutamol Sulfate Db-Oto-5 Loperamide Hydrochloride GEN1078 ANUMIGILIMAB Perflubutane Dexmedetomidine Albiglutide Bms-986458 Paclitaxel Albumin-Bound Vericiguat Aliskiren Tetracycline Hydrochloride E.coli Polysaccharide Regn7508 Serpina1(Human)-Aav8-1 ULVIPRUBART Epirubicin 10-1074-Ls Piromelatine More therapies…

    Learn about Your Condition

    Seizure Compulsive sexual behaviour Alveolar rhabdomyosarcoma Supranuclear palsy Peripheral artery thrombosis Biliary cancer metastatic Poor quality sleep Malabsorption Erythema Chronic lymphocytic leukaemia Bipolar I disorder Postprandial hypoglycaemia Biotinidase deficiency Squamous cell carcinoma Thymoma malignant More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Nutritional and Metabolic Diseases

  • Study of Avalotcagene Ontaparvovec for Patients Aged 12 and Older with Late-onset Ornithine Transcarbamylase Deficiency

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Ornithine transcarbamoylase deficiency
    Investigated Drugs:
    • Avalotcagene Ontaparvovec
    • Sodium Acetate (1-13C)
    • Prednisolone
    France Germany Italy The Netherlands Portugal Spain

  • Study of Insulin Treatment for Blood Glucose Control in Adult Critically Ill Patients with Stress Hyperglycemia

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Hyperglycaemia
    Investigated Drugs:
    • Insulin Human
    Belgium

  • Study on the Effects of Ertugliflozin and Sodium Intake on Blood Pressure in Overweight Adults with Type 2 Diabetes

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Type 2 diabetes mellitus
    Investigated Drugs:
    • Ertugliflozin
    The Netherlands

  • Study to Evaluate Plozasiran for Adults with High Triglycerides

    Not recruiting

    3 1
    Investigated Drugs:
    • Synthetic Double-Stranded Sirna Oligonucleotide Directed Against Apolipoprotein C-Iii Mrna And Covalently Linked To A Ligand Containing Three N-Acetylgalactosamine Residues
    Bulgaria Czechia France Germany Hungary Italy +3

  • Study on Long-Term Safety of Oral Lucerastat for Adults with Fabry Disease

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Fabry’s disease
    Investigated Drugs:
    • Lucerastat
    Austria Belgium France Germany Norway Poland +1

  • Study on the Safety and Effectiveness of Metformin Hydrochloride, Dapagliflozin, and Canagliflozin in Elderly Patients with Type 2 Diabetes

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Type 2 diabetes mellitus
    Investigated Drugs:
    • Canagliflozin
    • Empagliflozin
    • Dapagliflozin
    Italy
Previous Page
1 … 43 44 45 46 47 … 61
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!